Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P150031/S087

Vercise Deep Brain Stimulation (DBS) Systems

Boston Scientific Corp · Decision date Sep 19, 2025

FDA DECISIONP150031/S087

What did the FDA decide?

FDA records P150031/S087 as a supplement to PMA P150031, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Sep 19, 2025.

FDA approval order statement

the qualification of an alternate supplier, AVNA, for the IPG Pocket Template used with the Boston Scientific Neuromodulation Spinal Cord Stimulator and Deep Brain Stimulation Implantable Pulse Generators (IPGs). Additionally, the alternate supplier is changing the manufacturing process for the IPG Pocket Templates from chemical etching to metal stamping and laser etching
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Neurology
Decision date
Sep 19, 2025
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P150031/S087
Regulatory pathway
PMA supplement
Product code
NHL
Decision code
OK30
Decision date
Sep 19, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Stimulator, electrical, implanted, for parkinsonian symptoms.

Product code
NHL
FDA device class
3

For the original device and its historical approval scope, see PMA P150031. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P150031 · Original PMA

    VERCISE DEEP BRAIN STIMULATION (DBS)SYSTEM

  2. P150031/S087 received

    Application receipt date recorded by FDA.

  3. P150031/S087 · FDA decision

    30-Day Notice

  4. P150031/S089 · Related supplement

    Vercise Genus Deep Brain Stimulation (DBS) Systems

  5. P150031/S090 · Related supplement

    Vercise Deep Brain Stimulation (DBS) Systems

  6. P150031/S091 · Related supplement

    Vercise Deep Brain Stimulation (DBS) Systems

  7. P150031/S093 · Related supplement

    (Vercise Deep Brain Stimulation (DBS) Systems)

  8. P150031/S094 · Related supplement

    Vercise Deep Brain Stimulation (DBS) Systems

  9. P150031/S092 · Related supplement

    Deep Brain Stimulation (DBS) Systems

  10. P150031/S095 · Related supplement

    Vercise Deep Brain Stimulation (DBS) Systems

  11. P150031/S096 · Related supplement

    Vercise Deep Brain Stimulation (DBS) Systems

  12. P150031/S097 · Related supplement

    Vercise Deep Brain Stimulation (DBS) Systems

  13. P150031/S084 · Related supplement

    VERCISE DEEP BRAIN STIMULATION (DBS) SYSTEM

  14. P150031/S098 · Related supplement

    Vercise Genus DBS Systems; Vercise Gevia DBS Systems

  15. P150031/S102 · Related supplement

    Vercise Deep Brain Stimulation (DBS) Systems

Timeline entries are records held by MedtechLedger for P150031. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P150031

Product / regulatory recordCompanyPathwayDecision dateSource
Boston Scientific CorpPMA approvalDec 8, 2017FDA
Boston Scientific CorpPMA supplementDec 10, 2025FDA
Boston Scientific CorpPMA supplementDec 17, 2025FDA
Boston Scientific CorpPMA supplementJan 22, 2026FDA
Boston Scientific CorpPMA supplementMay 13, 2026FDA
Boston Scientific CorpPMA supplementMay 18, 2026FDA
Boston Scientific CorpPMA supplementMay 28, 2026FDA
Boston Scientific CorpPMA supplementJul 10, 2026FDA
Boston Scientific CorpPMA supplementJul 16, 2026FDA
Boston Scientific CorpPMA supplementAug 10, 2026FDA
Boston Scientific CorpPMA supplementSep 13, 2026FDA
Boston Scientific CorpPMA supplementSep 22, 2026FDA
Boston Scientific CorpPMA supplementOct 15, 2026FDA
Boston Scientific CorpPMA supplementOct 30, 2026FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Boston Scientific Corp

Headquarters
Not reported
FDA applicant address
25155 Rye Canyon Loop, Valencia, CA, 91355

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records